Articles about 'Cambridge Infectious Diseases'

What's so special about the bacteria in our bowels?

Scientists have discovered how poxviruses evade natural defences in living cells, and realised that drugs to stop them doing this are already available.

An international team of researchers has found a genetic variant that may explain why some people of African ancestry have naturally lower viral loads of HIV, reducing their risk of transmitting the virus and slowing progress of their own illness.

Cambridge scientists have identified a signature in the blood that could help predict how well an individual will respond to vaccines. The discovery, published today in Nature Communications, may explain why, even among vulnerable patient groups, some individuals have better responses to vaccines than others.

Should we be worried about frequent news reports of flu being detected in birds and other animals?

Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against SARS-CoV-2 – the virus that causes COVID-19 – and related coronaviruses.

Individuals who are obese may be more susceptible to severe COVID-19 because of a poorer inflammatory immune response, say Cambridge scientists.

Plan will accelerate a new approach to coronavirus vaccines research and development, to protect against COVID-19 variants and future pandemic threats from new coronaviruses

Scientists may have solved the question of why Ashkenazi Jews are significantly more susceptible to a rare genetic disorder known as Gaucher disease – and the answer may help settle the debate about whether they are less susceptible to tuberculosis (TB).

COVID-19 vaccinations that combine two or more distinct variants of the SARS-CoV-2 virus could offer protection against both current and future ‘variants of concern’, say scientists at the University of Cambridge and Medical University of Innsbruck.